Tausif Shaikh

Good morning. Thanks for the opportunity. Congrats on good set of numbers. First question is on patient volume growth of 10% during the quarter. Can you give us the split between B2B and B2C separately for the quarter? A nd also some color would be helpful for the strong volume growth which we have seen this quarter despite a seasonally weak quarter and a delayed monsoon.

That's helpful, Ma'am. Ma'am, my second question is related to your strategy in Tier-2 and Tier- 3 cities and against standalone labs. Wanted to check whether Metropolis is involved into getting into O&M agreement or regional lab management with the standalone players, where Metropolis starts managing these labs and start developing franchises and ultimately there's some kind of profit share agreement with the…

Is it possible, can you share the number of labs you have in this model?